Tripterygium wilfordii Hook. f. and Xinfeng Capsule in Rheumatoid Arthritis: A Review of Clinical Evidence, Molecular Mechanisms, and Translational Perspectives - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Efficacy and Mechanisms of Tripterygium wilfordii Hook. f. and Xinfeng Capsule in the Management of Rheumatoid Arthritis: A Comprehensive Review of Clinical Evidence and Translational Insights

  • By

  • Wen, Jianting

  • Liu, Jian

  • June 8, 2026

Share

  • 1

    Tripterygium wilfordii Hook. f. (TWHf) is traditionally used for rheumatoid arthritis (RA) but requires a comprehensive understanding of its efficacy and safety.

  • 2

    The review summarizes clinical evidence and mechanisms of TWHf-derived compounds, including Tripterygium Glycosides Tablets and Xinfeng Capsule in RA management.

  • 3

    Preclinical studies show TWHf compounds regulate RA-related processes through various signaling pathways and immune responses.

  • 4

    Xinfeng Capsule demonstrates broader regulatory effects compared to isolated monomers, enhancing efficacy and reducing toxicity.

  • 5

    Challenges in TWHf application include toxicity, lack of high-quality trials, and need for standardized formulations and personalized dosing.

Original Source(s)

Related Content